{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:54:46Z","timestamp":1761540886277},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T00:00:00Z","timestamp":1225152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/ncponc1244","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T13:05:50Z","timestamp":1225199150000},"page":"74-84","source":"Crossref","is-referenced-by-count":22,"title":["Prophylactic and therapeutic anticoagulation for thrombosis\u2014major issues in oncology"],"prefix":"10.1038","volume":"6","author":[{"given":"Marc","family":"Carrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes YY","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,28]]},"reference":[{"key":"BFncponc1244_CR1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA  et al. (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5: 632\u2013634","journal-title":"J Thromb Haemost"},{"key":"BFncponc1244_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom JW  et al. (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293: 715\u2013722","journal-title":"JAMA"},{"key":"BFncponc1244_CR3","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","volume":"18","author":"BA Hutten","year":"2000","unstructured":"Hutten BA  et al. (2000) Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 18: 3078\u20133083","journal-title":"J Clin Oncol"},{"key":"BFncponc1244_CR4","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P  et al. (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100: 3484\u20133488","journal-title":"Blood"},{"key":"BFncponc1244_CR5","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/archinte.164.15.1653","volume":"164","author":"LS Elting","year":"2004","unstructured":"Elting LS  et al. (2004) Outcomes and costs of deep venous thrombosis among patients with cancer. Arch Intern Med 164: 1653\u20131661","journal-title":"Arch Intern Med"},{"key":"BFncponc1244_CR6","doi-asserted-by":"publisher","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","volume":"126","author":"WH Geerts","year":"2004","unstructured":"Geerts WH  et al. (2004) Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 338S\u2013400S","journal-title":"Chest"},{"key":"BFncponc1244_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1245\/s10434-006-9183-9","volume":"14","author":"MJ Leonardi","year":"2007","unstructured":"Leonardi MJ  et al. (2007) A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol 14: 929\u2013936","journal-title":"Ann Surg Oncol"},{"key":"BFncponc1244_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2362.1988.tb01268.x","volume":"18","author":"JP Fricker","year":"1988","unstructured":"Fricker JP  et al. (1988) Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest 18: 561\u2013567","journal-title":"Eur J Clin Invest"},{"key":"BFncponc1244_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/00000658-200103000-00020","volume":"233","author":"RS McLeod","year":"2001","unstructured":"McLeod RS  et al. (2001) Subcutaneous heparin versus low molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg 233: 438\u2013444","journal-title":"Ann Surg"},{"key":"BFncponc1244_CR10","doi-asserted-by":"crossref","unstructured":"ENOXACAN Study Group (1997) Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. Br J Surg 84: 1099\u20131103","DOI":"10.1002\/bjs.1800840817"},{"key":"BFncponc1244_CR11","first-page":"668","volume":"5","author":"M Petrov","year":"2007","unstructured":"Petrov M  et al. (2007) Enoxaparin versus heparin prophylaxis for venous thromboembolism after abdominal oncologic surgery: a randomized double-blind controlled trial [abstract #668]. J Thromb Haemost 5: 668","journal-title":"J Thromb Haemost"},{"key":"BFncponc1244_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/bjs.1800820421","volume":"82","author":"D Bergqvist","year":"2005","unstructured":"Bergqvist D  et al. (2005) Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 units in 2070 patients. Br J Surg 82: 496\u2013501","journal-title":"Br J Surg"},{"key":"BFncponc1244_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijsu.2006.07.005","volume":"5","author":"JL Balibrea","year":"2007","unstructured":"Balibrea JL  et al. (2007) Bemiparin Cooperative Study Group in Surgery for Cancer. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice. Int J Surg 5: 114\u2013119","journal-title":"Int J Surg"},{"key":"BFncponc1244_CR14","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1111\/j.1538-7836.2006.02083.x","volume":"4","author":"G Simonneau","year":"2006","unstructured":"Simonneau G  et al. (2006) A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer. J Thromb Haemost 4: 1693\u20131700","journal-title":"J Thromb Haemost"},{"key":"BFncponc1244_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa012385","volume":"346","author":"D Bergqvist","year":"2002","unstructured":"Bergqvist D  et al. (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346: 975\u2013980","journal-title":"N Engl J Med"},{"key":"BFncponc1244_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/110241598750005534","volume":"164","author":"I Lausen","year":"1998","unstructured":"Lausen I  et al. (1998) Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomized controlled study of prolonged thromboprophylaxis. Eur J Surg 164: 657\u2013663","journal-title":"Eur J Surg"},{"key":"BFncponc1244_CR17","first-page":"56a","volume":"102","author":"MS Rasmussen","year":"2003","unstructured":"Rasmussen MS  et al. (2003) Prolonged prophylaxis with low molecular weight heparin (Dalteparin) following major abdominal surgery for malignancy. Blood 102: 56a","journal-title":"Blood"},{"key":"BFncponc1244_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","volume":"243","author":"G Agnelli","year":"2006","unstructured":"Agnelli G  et al. (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243: 89\u201395","journal-title":"Ann Surg"},{"key":"BFncponc1244_CR19","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/bjs.5154","volume":"92","author":"G Agnelli","year":"2005","unstructured":"Agnelli G  et al. (2005) Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 92: 1212\u20131220","journal-title":"Br J Surg"},{"key":"BFncponc1244_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.2007.14.1283","volume":"25","author":"GH Lyman","year":"2007","unstructured":"Lyman GH  et al. (2007) American society of clinical oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25: 1\u201316","journal-title":"J Clin Oncol"},{"key":"BFncponc1244_CR21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E","volume":"89","author":"LC Marras","year":"2000","unstructured":"Marras LC  et al. (2000) The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 89: 640\u2013646","journal-title":"Cancer"},{"key":"BFncponc1244_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1215\/15228517-2006-035","volume":"9","author":"R Simanek","year":"2007","unstructured":"Simanek R  et al. (2007) Venous thromboembolism and survival in patients with high-grade glioma. Neuro-Oncology 9: 89\u201395","journal-title":"Neuro-Oncology"},{"key":"BFncponc1244_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3171\/jns.2007.106.4.601","volume":"106","author":"TJ Semrad","year":"2007","unstructured":"Semrad TJ  et al. (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106: 601\u2013608","journal-title":"J Neurosurg"},{"key":"BFncponc1244_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3171\/jns.1978.49.3.0378","volume":"49","author":"D Cerrato","year":"1978","unstructured":"Cerrato D  et al. (1978) Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg 49: 378\u2013381","journal-title":"J Neurosurg"},{"key":"BFncponc1244_CR25","doi-asserted-by":"publisher","first-page":"A214","DOI":"10.1097\/00000542-199109001-00214","volume":"75","author":"E Melon","year":"1987","unstructured":"Melon E  et al. (1987) Deep venous thrombosis prophylaxis by low molecular weight heparin in neurosurgical patients. Anesthesiology 75: A214","journal-title":"Anesthesiology"},{"key":"BFncponc1244_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1055\/s-0038-1650250","volume":"75","author":"MT Nurmohamed","year":"1996","unstructured":"Nurmohamed MT  et al. (1996) Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost 75: 233\u2013238","journal-title":"Thromb Haemost"},{"key":"BFncponc1244_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJM199807093390204","volume":"339","author":"G Agnelli","year":"1998","unstructured":"Agnelli G  et al. (1998) Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339: 80\u201385","journal-title":"N Engl J Med"},{"key":"BFncponc1244_CR28","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1001\/archinte.160.15.2327","volume":"160","author":"A Iorio","year":"2000","unstructured":"Iorio A and Agnelli G (2000) Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Int Med 160: 2327\u20132332","journal-title":"Arch Int Med"},{"key":"BFncponc1244_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1097\/00006123-199811000-00039","volume":"43","author":"LD Dickinson","year":"1998","unstructured":"Dickinson LD  et al. (1998) Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 43: 1074\u20131081","journal-title":"Neurosurgery"},{"key":"BFncponc1244_CR30","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1378\/chest.122.6.1933","volume":"122","author":"SZ Goldhaber","year":"2002","unstructured":"Goldhaber SZ  et al. (2002) Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 122: 1933\u20131937","journal-title":"Chest"},{"key":"BFncponc1244_CR31","first-page":"363","volume":"59","author":"RL MacDonald","year":"2003","unstructured":"MacDonald RL  et al. (2003) Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurology 59: 363\u2013372","journal-title":"Surg Neurology"},{"issue":"Suppl","key":"BFncponc1244_CR32","first-page":"77s","volume":"25","author":"JR Perry","year":"2007","unstructured":"Perry JR  et al. (2007) PRODIGE: A phase III randomized placebo-controlled trial of thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma [abstract#2011]. J Clin Oncol 25 (Suppl): 77s","journal-title":"J Clin Oncol"},{"key":"BFncponc1244_CR33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/0002-9378(83)91205-X","volume":"145","author":"DL Clarke-Pearson","year":"1983","unstructured":"Clarke-Pearson DL  et al. (1983) Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Am J Obst Gynecol 145: 606\u2013613","journal-title":"Am J Obst Gynecol"},{"key":"BFncponc1244_CR34","first-page":"684","volume":"75","author":"DL Clarke-Pearson","year":"1990","unstructured":"Clarke-Pearson DL  et al. (1990) A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis. Obst Gynecol 75: 684\u2013689","journal-title":"Obst Gynecol"},{"key":"BFncponc1244_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ygyno.2007.03.004","volume":"105","author":"MH Einstein","year":"2007","unstructured":"Einstein MH  et al. (2007) Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review. Gynecol Onc 105: 813\u2013819","journal-title":"Gynecol Onc"},{"key":"BFncponc1244_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/00016348809004178","volume":"67","author":"E Borstad","year":"1988","unstructured":"Borstad E  et al. (1988) Comparison of low molecular weight heparin vs unfractionated heparin in gynecological surgery. Acta Obstet Gynecol Scand 67: 99\u2013103","journal-title":"Acta Obstet Gynecol Scand"},{"key":"BFncponc1244_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0028-2243(92)90044-Y","volume":"47","author":"R Kaaja","year":"1992","unstructured":"Kaaja R  et al. (1992) Comparison of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin, with or without dihydroergotamine, in abdominal hysterectomy. Eur J Obstet Gynecol Reprod Biol 47: 141\u2013145","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"BFncponc1244_CR38","first-page":"815","volume":"16","author":"GF von Tempelhoff","year":"2000","unstructured":"von Tempelhoff GF  et al. (2000) Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: a prospective randomized double-blind trial. Int J Oncol 16: 815\u2013824","journal-title":"Int J Oncol"},{"key":"BFncponc1244_CR39","first-page":"127","volume":"22","author":"Baykal","year":"2001","unstructured":"Baykal  et al. (2001) Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: a randomised prospective double-blind clinical study. Eur J Gynaecol Onc 22: 127\u2013130","journal-title":"Eur J Gynaecol Onc"},{"key":"BFncponc1244_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1445-2197.1983.tb02451.x","volume":"53","author":"JF Cade","year":"1983","unstructured":"Cade JF  et al. (1983) Prophylaxis of venous thrombosis after major thoracic surgery. ANZ J Surg 53: 301\u2013304","journal-title":"ANZ J Surg"},{"key":"BFncponc1244_CR41","first-page":"341","volume":"46","author":"JF Azorin","year":"1997","unstructured":"Azorin JF  et al. (1997) Efficacy and tolerability of fraxiparine in the prevention of thromboembolic complications in oncologic thoracic surgery. Ann Cardiol Angeiol (Paris) 46: 341\u2013347","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"BFncponc1244_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0090-4295(92)90203-9","volume":"39","author":"SW Bigg","year":"1992","unstructured":"Bigg SW  et al. (1992) Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology 39: 309\u2013313","journal-title":"Urology"},{"key":"BFncponc1244_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1081\/CNV-120005901","volume":"20","author":"IS Sawczuk","year":"2002","unstructured":"Sawczuk IS  et al. (2002) Low molecular weight heparin for venous thromboembolism prophylaxis in urologic oncologic surgery. Cancer Invest 20: 889\u2013892","journal-title":"Cancer Invest"},{"key":"BFncponc1244_CR44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/bjs.5782","volume":"94","author":"S Patiar","year":"2007","unstructured":"Patiar S  et al. (2007) Prevention of venous thromboembolism in surgical patients with breast cancer. Br J Surg 94: 412\u2013420","journal-title":"Br J Surg"},{"key":"BFncponc1244_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/(SICI)1096-9098(199805)68:1<41::AID-JSO9>3.0.CO;2-L","volume":"68","author":"PP Lin","year":"1998","unstructured":"Lin PP  et al. (1998) Deep venous thrombosis after orthopedic surgery in adult cancer patients. J Surg Onc 68: 41\u201347","journal-title":"J Surg Onc"},{"key":"BFncponc1244_CR46","first-page":"92","volume":"63","author":"DL Clarke-Pearson","year":"1984","unstructured":"Clarke-Pearson DL  et al. (1984) Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol 63: 92\u201398","journal-title":"Obstet Gynecol"},{"key":"BFncponc1244_CR47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/WNL.27.5.435","volume":"27","author":"AG Turpie","year":"1977","unstructured":"Turpie AG  et al. (1977) Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology 27: 435\u2013438","journal-title":"Neurology"},{"key":"BFncponc1244_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.amjmed.2005.06.058","volume":"1999","author":"PD Stein","year":"2006","unstructured":"Stein PD  et al. (2006) Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 1999: 60\u201368","journal-title":"Am J Med"},{"key":"BFncponc1244_CR49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1200\/JCO.2005.03.8877","volume":"24","author":"AA Khorana","year":"2006","unstructured":"Khorana AA  et al. (2006) Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24: 484\u2013490","journal-title":"J Clin Oncol"},{"key":"BFncponc1244_CR50","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","volume":"343","author":"M Levine","year":"1994","unstructured":"Levine M  et al. (1994) Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 343: 886\u2013889","journal-title":"Lancet"},{"issue":"suppl 1","key":"BFncponc1244_CR51","first-page":"563","volume":"5","author":"A Ciftci","year":"2007","unstructured":"Ciftci A  et al. (2007) Thrombosis in patients with lung cancer and the effectiveness of low warfarin prophylaxis on patients survival [abstract #563]. J Thromb Haemost 5 (suppl 1): 563","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"BFncponc1244_CR52","first-page":"OR059","volume":"3","author":"SK Haas","year":"2005","unstructured":"Haas SK  et al. (2005) Prevention of venous thromboembolism with low-molecular-weight heparin in patients with metastatic breast or lung cancer\u2014results of the TOPIC Studies [abstract #OR059]. J Thromb Haemost 3 (Suppl 1): OR059","journal-title":"J Thromb Haemost"},{"issue":"Suppl 2","key":"BFncponc1244_CR53","first-page":"PT488","volume":"5","author":"H Pelzer","year":"2007","unstructured":"Pelzer H  et al. (2007) Prospective, randomized open trial of enoxaparin in patient with advanced pancreatic cancer undergoing first-line chemotherapy [abstract #PT488]. J Thromb Haemost 5 (Suppl 2): PT488","journal-title":"J Thromb Haemost"},{"key":"BFncponc1244_CR54","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1378\/chest.06-2360","volume":"131","author":"J Hirsh","year":"2007","unstructured":"Hirsh J (2007) Risk of thrombosis with lenalidomide and its prevention with aspirin. Chest 131: 275\u2013277","journal-title":"Chest"},{"key":"BFncponc1244_CR55","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1538-7836.2007.02650.x","volume":"5","author":"A Amin","year":"2007","unstructured":"Amin A  et al. (2007) Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost 5: 1610\u20131616","journal-title":"J Thromb Haemost"},{"key":"BFncponc1244_CR56","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa041533","volume":"352","author":"Kucher","year":"2005","unstructured":"Kucher  et al. (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352: 969\u2013971","journal-title":"N Engl J Med"},{"key":"BFncponc1244_CR57","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMcp067264","volume":"356","author":"CW Francis","year":"2007","unstructured":"Francis CW (2007) Prophylaxis for thromboembolism in hospitalized medical patients. N Engl Med 356: 1438\u20131444","journal-title":"N Engl Med"},{"key":"BFncponc1244_CR58","doi-asserted-by":"crossref","unstructured":"Van Dongen CJ  et al.: Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD001100. 10.1002\/14651858.CD001100.pub2","DOI":"10.1002\/14651858.CD001100.pub2"},{"key":"BFncponc1244_CR59","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2141.2004.05292.x","volume":"128","author":"AYY Lee","year":"2003","unstructured":"Lee AYY (2003) Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 128: 291\u2013302","journal-title":"Br J Haematol"},{"key":"BFncponc1244_CR60","first-page":"286","volume":"87","author":"W Ageno","year":"2002","unstructured":"Ageno W  et al. (2002) Selecting patients for home treatment of deep vein thrombosis: the problem of cancer. Haematologica 87: 286\u2013291","journal-title":"Haematologica"},{"key":"BFncponc1244_CR61","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","volume":"106","author":"N Martel","year":"2005","unstructured":"Martel N  et al. (2005) Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106: 2710\u20132715","journal-title":"Blood"},{"key":"BFncponc1244_CR62","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMoa025313","volume":"349","author":"AYY Lee","year":"2003","unstructured":"Lee AYY  et al. (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349: 146\u2013153","journal-title":"N Engl J Med"},{"key":"BFncponc1244_CR63","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.amjmed.2006.02.022","volume":"119","author":"RD Hull","year":"2006","unstructured":"Hull RD  et al. (2006) Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med 119: 1062\u20131072","journal-title":"Am J Med"},{"key":"BFncponc1244_CR64","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","volume":"162","author":"G Meyer","year":"2002","unstructured":"Meyer G  et al. (2002) Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Int Med 162: 1729\u20131735","journal-title":"Arch Int Med"},{"key":"BFncponc1244_CR65","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/1076029606293692","volume":"12","author":"SR Deitcher","year":"2006","unstructured":"Deitcher SR  et al. (2006) Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period. Clin Applied Thromb Hemost 12: 389\u2013396","journal-title":"Clin Applied Thromb Hemost"},{"key":"BFncponc1244_CR66","doi-asserted-by":"crossref","unstructured":"The van Gogh Investigators (2007) Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med 357: 1094\u20131104","DOI":"10.1056\/NEJMoa064247"},{"key":"BFncponc1244_CR67","doi-asserted-by":"crossref","unstructured":"The PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study (2005) Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism. Circulation 112: 416\u2013422","DOI":"10.1161\/CIRCULATIONAHA.104.512834"},{"issue":"3 Suppl","key":"BFncponc1244_CR68","first-page":"401S","volume":"126","author":"HR Buller","year":"2204","unstructured":"Buller HR  et al. (2204) Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (3 Suppl): 401S\u2013428S","journal-title":"Chest"},{"key":"BFncponc1244_CR69","first-page":"369","volume":"16","author":"A Goerner","year":"1931","unstructured":"Goerner A (1931) The influence of anticlotting agents on transplantation growth of tumor tissue. J Lab Clin Med 16: 369\u2013372","journal-title":"J Lab Clin Med"},{"key":"BFncponc1244_CR70","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0.CO;2-E","volume":"74","author":"B Lebeau","year":"1994","unstructured":"Lebeau B  et al. (1994) Subcutaneous heparin treatment increases survival in small cell lung cancer. \u201cPetites Cellules\u201d Group. Cancer 74: 38\u201345","journal-title":"Cancer"},{"key":"BFncponc1244_CR71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/1097-0142(197507)36:1<129::AID-CNCR2820360109>3.0.CO;2-S","volume":"36","author":"EG Elias","year":"1975","unstructured":"Elias EG  et al. (1975) Heparin and chemotherapy in the management of inoperable lung carcinoma. Cancer 36: 129\u2013136","journal-title":"Cancer"},{"key":"BFncponc1244_CR72","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jama.1981.03310330021017","volume":"245","author":"LR Zacharski","year":"1981","unstructured":"Zacharski LR  et al. (1981) Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. JAMA 245: 831\u2013835","journal-title":"JAMA"},{"key":"BFncponc1244_CR73","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1200\/JCO.1989.7.8.993","volume":"7","author":"AP Chahinian","year":"1989","unstructured":"Chahinian AP  et al. (1989) A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol 7: 993\u20131002","journal-title":"J Clin Oncol"},{"key":"BFncponc1244_CR74","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1538-7836.2004.00871.x","volume":"2","author":"M Altinbas","year":"2004","unstructured":"Altinbas M  et al. (2004) A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost 2: 1266\u20131271","journal-title":"J Thromb Haemost"},{"key":"BFncponc1244_CR75","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1200\/JCO.2005.03.134","volume":"23","author":"CPW Klerk","year":"2005","unstructured":"Klerk CPW  et al. (2005) The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 23: 2130\u20132135","journal-title":"J Clin Oncol"},{"key":"BFncponc1244_CR76","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1200\/JCO.2004.10.002","volume":"22","author":"AK Kakkar","year":"2004","unstructured":"Kakkar AK  et al. (2004) Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 22: 1944\u20131948","journal-title":"J Clin Oncol"},{"key":"BFncponc1244_CR77","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4065\/81.6.758","volume":"81","author":"K Sideras","year":"2006","unstructured":"Sideras K  et al. (2006) Low-molecular-weight-heparin in patients with advanced cancer: a phase 3 clinical trial. Mayo Clin Proc 81: 758\u2013767","journal-title":"Mayo Clin Proc"},{"key":"BFncponc1244_CR78","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1002\/1097-0142(19840515)53:10<2046::AID-CNCR2820531007>3.0.CO;2-F","volume":"53","author":"LR Zacharski","year":"1984","unstructured":"Zacharski LR  et al. (1984) Effect of warfarin anticoagulation on survival in carcinoma of the lung colon, head and neck, and prostate. Final report of VA Cooperative Study 75. Cancer 53: 2046\u20132052","journal-title":"Cancer"},{"key":"BFncponc1244_CR79","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1200\/JCO.1997.15.11.3378","volume":"15","author":"LH Maurer","year":"1997","unstructured":"Maurer LH  et al. (1997) Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study. J Clin Oncol 15: 3378\u20133387","journal-title":"J Clin Oncol"},{"key":"BFncponc1244_CR80","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1538-7836.2007.02427.x","volume":"5","author":"A Lazo-Langner","year":"2007","unstructured":"Lazo-Langner A  et al. (2007) The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials. J Thromb Haemost 5: 729\u2013737","journal-title":"J Thromb Haemost"}],"container-title":["Nature Clinical Practice Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncponc1244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc1244","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncponc1244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc1244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:54:05Z","timestamp":1684443245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncponc1244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,28]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFncponc1244"],"URL":"https:\/\/doi.org\/10.1038\/ncponc1244","relation":{},"ISSN":["1743-4254","1743-4262"],"issn-type":[{"value":"1743-4254","type":"print"},{"value":"1743-4262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,28]]}}}